Thus, our results suggest that an intensive search for the rs121909567 (SERPINC1; ATBp3) founder mutation might be an important factor for the assessment of thrombotic disease susceptibility among the Roma population. This evidence concerns the gene SERPINC1 and thrombotic disease.